LAURA WELDISHOFER: Open Payments
NPI 1669861787 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$525 in 22 payments from 13 companies in 2025. Trend: 2023 $78 · 2024 $652 · 2025 $525
Food & beverage: $525
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $143 |
| Novartis Pharmaceuticals Corporation | 5 | $109 |
| AstraZeneca Pharmaceuticals LP | 2 | $48 |
| Merck Sharp & Dohme LLC | 2 | $43 |
| ABBVIE INC. | 1 | $26 |
| TerSera Therapeutics LLC | 1 | $25 |
| Pharmacosmos Therapeutics Inc. | 1 | $25 |
| Daiichi Sankyo Inc. | 1 | $22 |
| Gilead Sciences, Inc. | 1 | $20 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $20 |
Products named: RYBREVANT, SCEMBLIX, KEYTRUDA, KISQALI, IMBRUVICA, Zoladex, MONOFERRIC, Fabhalta.
Industry payments across OH — which companies pay providers there.
